Further to our previous news story relating to the continued supply of Priadel 200mg and 400mg tablets, the Competition and Markets Authority (CMA) have announced that Essential Pharma and the Department for Health and Social Care (DHSC) have agreed on a revised price for Priadel tablets.

The new prices were effective from the 5 November 2020 and following the usual price change mechanism rules, any generic or branded prescriptions for Priadel 200mg and 400mg tablets submitted for payment in November would be reimbursed at the old prices and the new prices would apply from the December 2020 onwards.

However, for November 2020, following representations made by PSNC, the DHSC have retrospectively determined that prescriptions for Priadel 200mg and 400mg tablets for November 2020 will be reimbursed at the new NHS list prices of £7.50 and £8.50, respectively.

Under the price change mechanism rules, any list price changes (up to and including the 8th of the month) for proprietary products and Drug Tariff Part VIIIA products where the price is based on a proprietary product take effect for any prescriptions dispensed in the following month. With the price increases for Priadel tablets coming into effect early in the month of November, a retrospective Drug Tariff price adjustment was requested by PSNC to ensure that pharmacy contractors are not faced with dispensing the higher priced stock at a loss against prescriptions for Priadel tablets submitted for payment in November 2020.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and, where appropriate, discuss the issue with the DHSC.